| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/25/1992 | DE4041482A1 Neue pharmazeutische verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine New pharmaceutical use carbocyclic and heterocyclic fused-dihydropyridines |
| 06/25/1992 | CA2058079A1 Method of treating thromboembolic disorders |
| 06/24/1992 | EP0491548A2 Processes and intermediates for thromboxane receptor antagonists |
| 06/24/1992 | EP0491351A2 Chimeric antibodies and their use |
| 06/24/1992 | EP0462207A4 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |
| 06/23/1992 | US5124326 Antiarrhythmic, hypotensive agents; diuretics |
| 06/23/1992 | CA1303987C Pharmaceutical composition having thrombolytic activity |
| 06/22/1992 | CA2058142A1 Thiadiazinones |
| 06/21/1992 | WO1992011294A1 Heparin derivatives |
| 06/21/1992 | WO1992011120A1 Method and apparatus for granulation |
| 06/21/1992 | CA2098600A1 Method and apparatus for granulation |
| 06/21/1992 | CA2075970A1 Heparin derivatives |
| 06/19/1992 | WO1992011377A1 Tissue plasminogen activator substitution variant |
| 06/19/1992 | CA2057951A1 Chimeric antibodies and their use |
| 06/19/1992 | CA2055572A1 Processes and intermediates for thromboxane receptor antagonists |
| 06/17/1992 | EP0490818A1 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof |
| 06/17/1992 | EP0490384A1 Process for the production of pasteurized and iron-free human transferrin |
| 06/17/1992 | CN1061971A Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 06/16/1992 | US5122542 Hypotriglyceridemic use of certain bis (3,5-di-alkyl-4-hydroxyphenylthio)methanes |
| 06/16/1992 | CA1303619C Alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the same |
| 06/16/1992 | CA1303534C Human anti-rh(d) monoclonal antibodies |
| 06/16/1992 | CA1303533C Human anti-rh(d) monoclonal antibodies |
| 06/14/1992 | WO1992010570A1 Leukemia inhibitory factor receptors |
| 06/14/1992 | WO1992010190A1 Novel csaids |
| 06/14/1992 | CA2098177A1 Csaids |
| 06/14/1992 | CA2097291A1 Leukemia inhibitory factor receptors |
| 06/11/1992 | WO1992009567A1 Anti-inflammatory compounds |
| 06/10/1992 | EP0489647A2 N,O-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them |
| 06/10/1992 | EP0489201A1 Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant DNA and transformed microorganisms |
| 06/10/1992 | EP0174367B1 Hosts and methods for producing recombinant products in high yields |
| 06/09/1992 | US5120859 Chimeric amino acid analogues |
| 06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
| 06/09/1992 | US5120749 Treatment of anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellulosr immunity, parturtition, fetal lung maturation, and cellular differentiation |
| 06/09/1992 | US5120744 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
| 06/09/1992 | US5120736 Treatment of functional dysuria associated with hyperactivity of adrenergic smypathetic nervous system |
| 06/09/1992 | US5120731 Stabilization of perfluorocarbon emulsions, and perfluorinated heterocyclic compounds usable as emulsion-stabilizing additives |
| 06/09/1992 | US5120647 Phospholipase a2 inhibitor |
| 06/09/1992 | US5120537 Factor X or fragment thereof having little or no serine esterase activity, which is capable of binding with factor V in the blood of a mammal, and a carrier |
| 06/08/1992 | WO1992010575A1 Bifunctional inhibitors of thrombin and platelet activation |
| 06/08/1992 | CA2096545A1 Bifunctional inhibitors of thrombin and platelet activation |
| 06/08/1992 | CA2056967A1 Use of organic compounds |
| 06/04/1992 | CA2056878A1 N,o-sulphated heparosans, process for preparing them and pharmaceutical compositions containing them |
| 06/03/1992 | EP0488345A1 1,4-Dihydropyridine derivatives and methods of producing the same |
| 06/03/1992 | EP0488079A1 Oxadiazolylmethylpurines, their preparation, and their pharmaceutical use |
| 06/03/1992 | EP0487930A1 Process for preparing benzo[C]phenanthridinium derivatives, and novel compounds prepared by said process |
| 06/03/1992 | EP0487629A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/03/1992 | EP0370036B1 Modified factor vii/viia |
| 06/03/1992 | CN1061600A Chemical process |
| 06/02/1992 | US5118790 Analogs of hirudin |
| 06/02/1992 | US5118701 Antiischemic agents, anticoagulants |
| 06/02/1992 | US5118505 Ginkge extract and folic, lipoic and(or) vitamin b |
| 06/02/1992 | CA1302405C Ergoline derivatives |
| 06/02/1992 | CA1302272C Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and theiruse in treating clot formation |
| 05/29/1992 | WO1992008735A1 Novel cytokine |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | WO1992008479A1 Tissue factor based prothrombin time reagent |
| 05/29/1992 | WO1992008472A1 Antithrombosis agents |
| 05/29/1992 | CA2101759A1 Antithrombosis agents |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2095840A1 Cytokine |
| 05/27/1992 | EP0487238A2 A method for blocking platelet adhesion to collagen |
| 05/27/1992 | EP0487095A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | DE4037941A1 Cyclopentanetherderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentanetherderivate, processes for their preparation and their pharmaceutical use |
| 05/26/1992 | US5116971 Platelt-activating-factor antagonist |
| 05/26/1992 | US5116963 Anticoagulants |
| 05/26/1992 | US5116843 Anticoagulants, hypotensive agents and cardiovascular disorder |
| 05/26/1992 | US5116837 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines |
| 05/26/1992 | CA1302005C Aminoacid derivatives as antihypertensives |
| 05/24/1992 | WO1992009573A2 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 05/24/1992 | CA2096848A1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 05/23/1992 | CA2055950A1 Pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/23/1992 | CA2055946A1 Chemical process |
| 05/20/1992 | EP0486385A1 Imidazole derivatives, process for their fabrication and pharmaceutical compositions containing them |
| 05/20/1992 | EP0486001A1 Recombinant urinary trypsin inhibitor fragments and drug composition |
| 05/20/1992 | EP0485748A2 Salts of glycosaminoglycans with esters of aminoacids, preparation thereof and pharmaceutical formulations containing them |
| 05/20/1992 | EP0209539B1 Homogeneous erythropoietin |
| 05/19/1992 | US5114926 Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses |
| 05/19/1992 | US5114922 Animal extracts from leeches |
| 05/19/1992 | US5114916 Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants |
| 05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
| 05/19/1992 | US5114710 M-csf as a therapeutic agent for thrombocytopenia |
| 05/19/1992 | CA1301172C Thianaphthene derivatives, their production and use |
| 05/19/1992 | CA1301063C Biologically degradable superparamagnetic materials for use in clinicalapplications |
| 05/17/1992 | WO1992008792A2 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| 05/17/1992 | CA2096329A1 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| 05/15/1992 | CA2055325A1 Novel imidazole derivatives, process for preparing them and pharmaceutical compositions containing them |
| 05/14/1992 | WO1992007869A1 Inhibitors and substrates of thrombin |
| 05/14/1992 | WO1992007584A1 Pharmaceutical preparation for the treatment of prolonged coagulation time |
| 05/14/1992 | WO1992007578A1 Use of protective agents against reactive oxygen species |
| 05/14/1992 | WO1992007568A1 η-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS |
| 05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/1992 | CA2095356A1 Pharmaceutical preparation for the treatment of prolonged coagulation time |
| 05/14/1992 | CA2055425A1 Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same |
| 05/14/1992 | CA2055146A1 Method for blocking platelet adhesion to collagen |
| 05/13/1992 | EP0485219A2 Medicaments for preventing and treating circulatory organ diseases containing spiro-3-heteroazolidine compounds |
| 05/13/1992 | EP0485217A2 Hydantoin derivatives, and their use in preventing and treating diabetic complications and circulatory organ diseases |
| 05/13/1992 | EP0484477A1 Maturation of hemopoietic cells |
| 05/13/1992 | EP0484437A1 Renal-selective prodrugs for the treatment of hypertension |
| 05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |